(UMRX) |
| 0 (0%) 02-26 16:37 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 13.82 |
| Resistance 1: | 12.56 |
| Pivot price: | 11.75 |
| Support 1: | 10.51 |
| Support 2: | 8.74 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 05 Oct 2020
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress - PR Newswire
Mon, 02 Mar 2020
Unum Therapeutics Implements Strategic Restructuring to - GlobeNewswire
Tue, 03 Apr 2018
Unum Therapeutics Announces Closing of Initial Public - GlobeNewswire
Thu, 29 Mar 2018
UMRX IPO News - Immuno-oncology biotech Unum Therapeutics prices $69 million IPO at $12 low end - renaissancecapital.com
Thu, 26 Feb 2026
Thu, 26 Feb 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
